Advertisement
UK markets closed

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     

  • CRUDE OIL

    78.48
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,323.00
    -8.20 (-0.35%)
     

  • DOW

    38,850.15
    -2.12 (-0.01%)
     

  • Bitcoin GBP

    50,455.35
    +64.32 (+0.13%)
     

  • CMC Crypto 200

    1,310.21
    -54.92 (-4.02%)
     

  • NASDAQ Composite

    16,310.53
    -38.71 (-0.24%)
     

  • UK FTSE All Share

    4,522.99
    +53.90 (+1.21%)
     
Money:

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Enanta Pharmaceuticals, Inc. :ENTA-US: Earnings Analysis: Q3, 2017 By the Numbers : September 18, 2017

CapitalCube
Updated
Enanta Pharmaceuticals, Inc. :ENTA-US: Earnings Analysis: Q3, 2017 By the Numbers : September 18, 2017

Categories: Yahoo FinanceGet free summary analysis Enanta Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Enanta Pharmaceuticals, Inc. – Achillion Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated, SciClone Pharmaceuticals, Inc., AbbVie, Inc., Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company and Novartis AG ... Read more (Read more...)

Continue reading